Wells Fargo Upgrades RxSight Inc. (RXST) to Overweight

Wells Fargo analyst Lawrence Biegelsen upgraded RxSight Inc. (NASDAQ: RXST) from Equal Weight to Overweight with a price target of $42.00.

For an analyst ratings summary and ratings history on RxSight Inc. click here. For more ratings news on RxSight Inc. click here.

Shares of RxSight Inc. closed at $37.53 yesterday.

You May Also Be Interested In

• HSBC Upgrades Synopsys (SNPS) to Buy, 'Transforming into an AI beneficiary'
• Citi Upgrades Kerry Group PLC (KYG:ID) (KRYAY) to Buy
• RBC Capital Upgrades Healius Limited (HLS:AU) (PHCRF) to Sector Perform